Covered recipient · General Payments record
MARK G FRANZ
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$2,334.67
- Reported across 165 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.56 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $205.40 | 23 |
| GlaxoSmithKline, LLC. | $41.67 | 2 |
| Novo Nordisk AS | $34.04 | 2 |
| Valinor Pharma, LLC | $20.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.31 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751015 | CMS |
| ABBVIE INC. | $17.81 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751017 | CMS |
| ABBVIE INC. | $5.07 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751019 | CMS |
| ABBVIE INC. | $2.49 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751021 | CMS |
| ABBVIE INC. | $3.82 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751023 | CMS |
| ABBVIE INC. | $8.39 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751025 | CMS |
| ABBVIE INC. | $6.25 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751027 | CMS |
| ABBVIE INC. | $4.11 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751029 | CMS |
| ABBVIE INC. | $7.44 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751031 | CMS |
| ABBVIE INC. | $23.31 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751033 | CMS |
| ABBVIE INC. | $7.44 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751035 | CMS |
| ABBVIE INC. | $16.40 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751037 | CMS |
| ABBVIE INC. | $2.88 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751039 | CMS |
| ABBVIE INC. | $8.44 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751041 | CMS |
| ABBVIE INC. | $9.21 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751043 | CMS |
| ABBVIE INC. | $13.02 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751045 | CMS |
| ABBVIE INC. | $4.55 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751047 | CMS |
| ABBVIE INC. | $20.34 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751049 | CMS |
| ABBVIE INC. | $6.04 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751051 | CMS |
| ABBVIE INC. | $15.59 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751053 | CMS |
| ABBVIE INC. | $11.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751055 | CMS |
| ABBVIE INC. | $4.80 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751057 | CMS |
| ABBVIE INC. | $4.67 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103751059 | CMS |
| GlaxoSmithKline, LLC. | $21.93 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244148 | CMS |
| GlaxoSmithKline, LLC. | $19.74 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115988996 | CMS |
| Novo Nordisk Inc | $20.88 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096945195 | CMS |
| Novo Nordisk Inc | $13.16 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097827806 | CMS |
| Valinor Pharma, LLC | $20.45 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130827023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.